Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016		Sep. 30, 2015
Cash Flows from Operating Activities:
Net loss	$ (1,232,683)		$ (1,592,144)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	41,966		39,760
Stock-based compensation expense	48,000		722,090
Changes in operating assets and liabilities:
Prepaid expenses	35,815		7,838
Inventory	171,491		66,611
Accounts payable and accounts payable – related parties	49,637		(677)
Accrued expenses and accrued expenses – related parties	97,866		25,086
Net Cash Used in Operating Activities	(787,908)		(731,436)
Cash Flows from Investing Activities:
Cost of registering patents	(17,941)		(17,955)
Net Cash Used in Investing Activities	(17,941)		(17,955)
Cash Flows from Financing Activities:
Issuance of common stock for cash	160,000		676,000
Issuance of notes payable	0		75,000
Principal payments on notes payable	(56,534)		(40,516)
Net Cash Provided by Financing Activities	103,466		710,484
Effect of Foreign Currency Exchange Rates	(5,507)		18,611
Net decrease in cash	(707,890)		(20,296)
Cash as of beginning of the period	745,078	[1]	140,496
Cash as of end of the period	37,188		120,200
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	8,246		1,006
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
Settlement of accounts payable and accrued expenses with notes payable – related parties	1,617,881
Financing of insurance policies	$ 66,755		$ 49,964

[1] The condensed consolidated balance sheet as of December 31, 2015 has been prepared using information from the audited consolidated balance sheet as of that date.